Southern African HIV Clinicians Society Conference 2018 – Presentations:
WEDNESDAY, 24 OCTOBER 2018
Pre-conference workshop A
- Basics to understand HIV drug resistance | Carole Wallis
- How do we measure HIV drug resistance | Monique Nijhuis
- Impact of ART resistance in sub Saharan Africa | Elliot Raizes
- Barriers to adherence: predictors and markers of treatment response | John de Wit
- Understanding virological failure | Annemarie Wensing
- Integrated adherence counselling using biomedical and socio-economic information | Lucas Hermans
- Therapy success and failure: first, second and third line therapy | Francois Venter
- DTG Global roll out | Ava Avalos
- Future trends of drug resistance and prospects of antiviral therapy | Douglas Richman
Pre-conference workshop B
- How to administer PrEP: a typical clinical consultation | Muhangwi Mulaudzi
Session 1A
- Previously on PrEP, now pregnant. What to do? | Tshidi Sebitloane
- Teen adherence | Juliet Houghton
- Breast abnormalities in adolescents receiving ART | Jackie Dunlop
Session 1B
- Case presentation: Treatment experienced and PrEP | Eric Hefer
- Case presentation: Pirates of the abdomen | Kim Pieton
- Case presentation: A palatal mass and a head-scratcher | Michelle Venter
Session 1C
- Cases – primary healthcare, rural doctors | Ndiviwe Mphothulo, Jenny Nash
- Managing HIV and the role of the primary healthcare team | Jenny Nash
- Missed Clinical Management Opportunities | Gloria Mthombeni
- Nurse cases | Talitha Crowley
Session 3
- Opening | Desmond Martin
- HIV replication: principles and prevention | Douglas Richman
THURSDAY, 25 OCTOBER 2018
Session 4A
- Not deaf or dead! The seven-year journey of bedaquiline as a third choice for all South Africans with MDR-TB, as told by one fortunate MDR-TB survivor | Arne von Delft
- Stop Stockouts Project and launch of the 4th annual medicine availability survey | Tinne Gils
Session 5
- How are we doing with Universal Test and Treat? | Francois Venter
- How are we doing with viral suppression? | Sergio Carmona
- Pretreatment drug resistance and new treatment paradigms in first-line ART | Michelle Moorhouse
Session 6A
- Pharmacovigilance | Karen Cohen
- Pregnancy register | Mukesh Dheda
- Registers and centralised reporting | Ruth Lancaster
Session 6B
- Swallowing tablets | Melanie Collins
- Optimising formulations | Carol Ruffell
- The latest on infant testing, and how to access | Gayle Sherman
- Treating children | Helena Rabie
Session 6C
- Whistle-blowing in the health-sector | Marije Versteeg-Mojanaga
- Ethics on how health budgets are split | Marije Versteeg-Mojanaga
Session 8A
- Kaposi Sarcoma and Lymphoma | Zainab Mohamed
Session 8B
- Viral resistance first-line and second-line | Graeme Meintjes
- Third-line treatment. Feedback on outcome of patients on national third-line regimen | Michelle Moorhouse
Session 8C
- Non-biomedical approaches | Sue Goldstein
- Condoms | Mags Beksinska
- Update on trials of vaccines and monoclonals in SA; how PrEP could augment these approaches | Fatima Laher
- Voluntary medical male circumcision | Limakatso Lebina
- Treatment as prevention | Francois Venter
Session 9A
- NRTIs (Yunus Moosa)
- NNRTIs (Michelle Moorhouse)
- Drug-drug interaction (Gary Maartens)
Session 9C
- What are the numbers telling us | Andrew Boulle
- How the epidemic informs resource planning | Zukiswa Pinini
- Cost effectiveness of TLD versus TEE | Gesine Meyer-Rath
Session 10A
- HIVDB genotypic drug resistance interpretation program | Robert Shafer
Session 10B
- Integrating HIV prevention with other services | Natasha Davies
- How to tell a teenager they have HIV: A practical approach | Julia Turner
- Uptake and yield of a 24/7 HIV testing service across four Eastern Cape hospital Emergency departments | Dave Stead
Session 11
- Implications of scarcer resources for 90:90:90 | Gloria Maimela
FRIDAY, 26 OCTOBER 2018
Session 12
- Why do we need cure | John Mellors
- How do you measure cure | Monique Nijhuis
Session 13A
- An approach to intracranial mass lesions in HIV patients | Dave Stead
- Endemic mycoses in HIV patients | Jade Mogambery
- An approach to chronic diarrhoea | Sipho Dlamini
Session 13B
- TB in adults and HIV-TB co-infection | Ndiviwe Mphothulo
- TB and HIV co-infection including IRIS | Richard Lessells
Session 13C
- Injecting drug users in the region | Andrew Scheibe
- Engaging with sex workers | Naomi Hill
- Testing in taxi ranks | Thandeka Khoza
Session 15
Session 16A
- Case presentation | Farai Russell Sigauke
- Clinical skill building | Richard Lessells
Session 16B
- Should the private sector be treating TB? Yes | Moeketsi Mathe
Session 16C
- Where are we with PMTCT, including epidemiology | Landon Myer
- Transmission of HIV in breastfeeding | Ameena Goga
- Pregnant women on ART – programmatic issues | Coceka Mnyani
Session 17
- Dolutegravir in pregnancy – overview | Landon Myer
- DolPHIN-1 | Catherine Orrell
- Dolutegravir rollout | Steven Smith
SATURDAY, 27 OCTOBER 2018
Session 19
- Vaccinations – overview | Benjamin Kagina
- Influenza vaccines | Marta Nunes
- SAHCS vaccination guidelines | Sipho Dlamini
Session 20A
- Inflammation | Dave Spencer
- Hypertension | Ebrahim Variava
- Obesity | Denasha Reddy
- Mental health | John Joska
- Injection drug use, HIV and hepatitis | Moeketsi Mathe
Session 20B
- Ethico-legal framework for biobank research in SA | Safia Mahomed
- EMGuidance | Mohammed Dalwai
Session 20C
- Strategies to achieve STI control in South Africa | Remco Peters
- Hepatitis C | Andrew Scheibe
Session 22A
- Care of aging patients | Marlin McKay
- Palliative care | Dave Spencer
Session 22B
- New ARVs and surveillance | Michelle Moorhouse
- Low-dose darunavir | Francois Venter
Session 22C
- Constructing TB cascades to inform TB programme improvement | Kate Rees)
- Continued Use of PrEP among Sex Workers in Six Sites in South Africa | Cara O’Connor
- Linking paediatric, adolescent and adult patients to care through the implementation of clinic navigators in high volume facilities | Chantal Smith
- Perceptions of HIV-Self Screening | Nthabiseng Koloane
- Viral load suppression among pregnant women presenting on ART in antenatal care; Chiredzi District Zimbabwe | Talent Maphosa
- Triple-NRTI regimens while on TB treatment in a resource constrained setting – a paediatric cohort analysis | Jennifer Minnaar
- Youth Care Clubs: Optimising clinic time, fostering peer support, improving adherence | Moira Beery
Session 23A
- Vaccination guidelines | Sipho Dlamini
- Safer conception guidelines | Natasha Davies
- Adult antiretroviral therapy guidelines | Michelle Moorhouse
- Palliative care guidelines | Dave Spencer
Session 23B
- What is new in adherence | Catherine Orrell
- Virological monitoring – how it relates to adherence | Richard Lessells
- Self screening | Naleni Rhagnath
Session 23C
- Quality Improvement | Lauren de Kock
Session 24